End user conditions of product sale

Choose your country

Select your country

Did you know? Fujirebio and Covid-19

In a reply to the Covid-19 pandemic impacting the world since early 2020, Fujirebio plays an important role as a healthcare partner, offering various testing solutions that are used across the world today to support fast and trustworthy diagnosis.

Read more here

Please note that the conditions below are for Fujirebio Europe end user customers.

For conditions of sale for our Fujirebio Diagnostics AB customers (mostly EIA tumor markers and raw materials) or if you have any doubts please contact us.

Conditions of sale Fujirebio